Joseph P. Hagan
2016 - Regulus Therapeutics
In 2016, Joseph P. Hagan earned a total compensation of $4M as Chief Operations Officer at Regulus Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $107,900 |
| Option Awards | $3,326,416 |
| Salary | $413,670 |
| Other | $2,293 |
| Total | $3,950,279 |
Hagan received $3.3M in option awards, accounting for 84% of the total pay in 2016.
Hagan also received $100K in bonus, $107.9K in non-equity incentive plan, $413.7K in salary and $2.3K in other compensation.
Rankings
In 2016, Joseph P. Hagan's compensation ranked 2,270th out of 14,075 executives tracked by ExecPay. In other words, Hagan earned more than 83.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,270 out of 14,075 | 84th |
Division Manufacturing | 785 out of 5,489 | 86th |
Major group Chemicals And Allied Products | 230 out of 1,895 | 88th |
Industry group Drugs | 167 out of 1,538 | 89th |
Industry Pharmaceutical Preparations | 132 out of 1,176 | 89th |
Source: SEC filing on April 28, 2017.
Hagan's colleagues
We found two more compensation records of executives who worked with Joseph P. Hagan at Regulus Therapeutics in 2016.
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019